TLPH Q3 2018 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$377,000-74.6% YoY

Gross Profit

-$4M-1098.1% margin

Operating Income

-$9M-2474.3% margin

Net Income

-$12M-3304.5% margin

EPS (Diluted)

$-4.15

QoQ Revenue Growth

-53.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$78M

Total Liabilities

$116M

Stockholders' Equity

-$38M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$377,000	$1M	-74.6%
Gross Profit	-$4M	-$4M	+7.1%
Operating Income	-$9M	-$9M	-5.3%
Net Income	-$12M	-$13M	+4.3%